Cargando…

Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL

BACKGROUND: Under the influences of chemotherapy regimens, clinical staging, immunologic expressions and other factors, the survival rates of patients with diffuse large B-cell lymphoma (DLBCL) are different. The accurate prediction of mortality hazards is key to precision medicine, which can help c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Shuanglong, Zhao, Zhiqiang, Yu, Hongmei, Wang, Lei, Zheng, Chuchu, Huang, Xueqian, Yang, Zhenhuan, Xing, Meng, Lu, Qing, Luo, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791789/
https://www.ncbi.nlm.nih.gov/pubmed/33413321
http://dx.doi.org/10.1186/s12911-020-01354-0
_version_ 1783633667554279424
author Fan, Shuanglong
Zhao, Zhiqiang
Yu, Hongmei
Wang, Lei
Zheng, Chuchu
Huang, Xueqian
Yang, Zhenhuan
Xing, Meng
Lu, Qing
Luo, Yanhong
author_facet Fan, Shuanglong
Zhao, Zhiqiang
Yu, Hongmei
Wang, Lei
Zheng, Chuchu
Huang, Xueqian
Yang, Zhenhuan
Xing, Meng
Lu, Qing
Luo, Yanhong
author_sort Fan, Shuanglong
collection PubMed
description BACKGROUND: Under the influences of chemotherapy regimens, clinical staging, immunologic expressions and other factors, the survival rates of patients with diffuse large B-cell lymphoma (DLBCL) are different. The accurate prediction of mortality hazards is key to precision medicine, which can help clinicians make optimal therapeutic decisions to extend the survival times of individual patients with DLBCL. Thus, we have developed a predictive model to predict the mortality hazard of DLBCL patients within 2 years of treatment. METHODS: We evaluated 406 patients with DLBCL and collected 17 variables from each patient. The predictive variables were selected by the Cox model, the logistic model and the random forest algorithm. Five classifiers were chosen as the base models for ensemble learning: the naïve Bayes, logistic regression, random forest, support vector machine and feedforward neural network models. We first calibrated the biased outputs from the five base models by using probability calibration methods (including shape-restricted polynomial regression, Platt scaling and isotonic regression). Then, we aggregated the outputs from the various base models to predict the 2-year mortality of DLBCL patients by using three strategies (stacking, simple averaging and weighted averaging). Finally, we assessed model performance over 300 hold-out tests. RESULTS: Gender, stage, IPI, KPS and rituximab were significant factors for predicting the deaths of DLBCL patients within 2 years of treatment. The stacking model that first calibrated the base model by shape-restricted polynomial regression performed best (AUC = 0.820, ECE = 8.983, MCE = 21.265) in all methods. In contrast, the performance of the stacking model without undergoing probability calibration is inferior (AUC = 0.806, ECE = 9.866, MCE = 24.850). In the simple averaging model and weighted averaging model, the prediction error of the ensemble model also decreased with probability calibration. CONCLUSIONS: Among all the methods compared, the proposed model has the lowest prediction error when predicting the 2-year mortality of DLBCL patients. These promising results may indicate that our modeling strategy of applying probability calibration to ensemble learning is successful.
format Online
Article
Text
id pubmed-7791789
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77917892021-01-11 Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL Fan, Shuanglong Zhao, Zhiqiang Yu, Hongmei Wang, Lei Zheng, Chuchu Huang, Xueqian Yang, Zhenhuan Xing, Meng Lu, Qing Luo, Yanhong BMC Med Inform Decis Mak Research Article BACKGROUND: Under the influences of chemotherapy regimens, clinical staging, immunologic expressions and other factors, the survival rates of patients with diffuse large B-cell lymphoma (DLBCL) are different. The accurate prediction of mortality hazards is key to precision medicine, which can help clinicians make optimal therapeutic decisions to extend the survival times of individual patients with DLBCL. Thus, we have developed a predictive model to predict the mortality hazard of DLBCL patients within 2 years of treatment. METHODS: We evaluated 406 patients with DLBCL and collected 17 variables from each patient. The predictive variables were selected by the Cox model, the logistic model and the random forest algorithm. Five classifiers were chosen as the base models for ensemble learning: the naïve Bayes, logistic regression, random forest, support vector machine and feedforward neural network models. We first calibrated the biased outputs from the five base models by using probability calibration methods (including shape-restricted polynomial regression, Platt scaling and isotonic regression). Then, we aggregated the outputs from the various base models to predict the 2-year mortality of DLBCL patients by using three strategies (stacking, simple averaging and weighted averaging). Finally, we assessed model performance over 300 hold-out tests. RESULTS: Gender, stage, IPI, KPS and rituximab were significant factors for predicting the deaths of DLBCL patients within 2 years of treatment. The stacking model that first calibrated the base model by shape-restricted polynomial regression performed best (AUC = 0.820, ECE = 8.983, MCE = 21.265) in all methods. In contrast, the performance of the stacking model without undergoing probability calibration is inferior (AUC = 0.806, ECE = 9.866, MCE = 24.850). In the simple averaging model and weighted averaging model, the prediction error of the ensemble model also decreased with probability calibration. CONCLUSIONS: Among all the methods compared, the proposed model has the lowest prediction error when predicting the 2-year mortality of DLBCL patients. These promising results may indicate that our modeling strategy of applying probability calibration to ensemble learning is successful. BioMed Central 2021-01-07 /pmc/articles/PMC7791789/ /pubmed/33413321 http://dx.doi.org/10.1186/s12911-020-01354-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Fan, Shuanglong
Zhao, Zhiqiang
Yu, Hongmei
Wang, Lei
Zheng, Chuchu
Huang, Xueqian
Yang, Zhenhuan
Xing, Meng
Lu, Qing
Luo, Yanhong
Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL
title Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL
title_full Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL
title_fullStr Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL
title_full_unstemmed Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL
title_short Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL
title_sort applying probability calibration to ensemble methods to predict 2-year mortality in patients with dlbcl
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791789/
https://www.ncbi.nlm.nih.gov/pubmed/33413321
http://dx.doi.org/10.1186/s12911-020-01354-0
work_keys_str_mv AT fanshuanglong applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl
AT zhaozhiqiang applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl
AT yuhongmei applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl
AT wanglei applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl
AT zhengchuchu applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl
AT huangxueqian applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl
AT yangzhenhuan applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl
AT xingmeng applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl
AT luqing applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl
AT luoyanhong applyingprobabilitycalibrationtoensemblemethodstopredict2yearmortalityinpatientswithdlbcl